APEX Tissue is a 50-gene, targeted Next-Generation Sequencing (NGS) hotspot panel, which is specially curated for the detection of sensitizing and resistance genetic alterations to guide personalized treatment selection in patients with solid tumours.
Patient profiles suitable for APEX Tissue include Non-Small Cell Lung Cancer, Colorectal Cancer, and Breast Cancer.
For more information, contact us or visit https://mirxes.com/cancer_treatment_selection/